Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc., often referred to as Prestige Brands, is a leading player in the consumer healthcare industry, headquartered in Tarrytown, New York. Founded in 1999, the company has established a strong presence across North America and various international markets, focusing on over-the-counter (OTC) healthcare products. Prestige Brands is renowned for its diverse portfolio, which includes well-known brands in categories such as pain relief, cold and allergy, and personal care. Their commitment to quality and innovation sets them apart, with products designed to meet the evolving needs of consumers. Notable achievements include strategic acquisitions that have expanded their market reach and solidified their position as a trusted name in healthcare. With a focus on delivering effective solutions, Prestige Consumer Healthcare continues to thrive in a competitive landscape.
DitchCarbon Score
How does Prestige Consumer Healthcare Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Prestige Consumer Healthcare Inc's score of 21 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Prestige Consumer Healthcare Inc's reported carbon emissions
In 2024, Prestige Consumer Healthcare Inc reported total carbon emissions of approximately 149.9 million tonnes CO2e. This figure includes about 1.4 million tonnes CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and around 7.1 million tonnes CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity. The majority of their emissions, approximately 141.3 million tonnes CO2e, fall under Scope 3, which encompasses all other indirect emissions in the value chain. In comparison, the company's 2021 emissions data indicated a total of about 107.2 million tonnes CO2e, with Scope 1 emissions at approximately 1.3 million tonnes CO2e, Scope 2 emissions at around 5.5 million tonnes CO2e, and Scope 3 emissions at about 100.3 million tonnes CO2e. This reflects a significant increase in total emissions over the three-year period. Currently, Prestige Consumer Healthcare Inc has not established specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further development in their sustainability strategy. As the company continues to grow, addressing carbon emissions and implementing effective reduction strategies will be crucial for aligning with industry standards and climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2021 | 2024 | |
|---|---|---|
| Scope 1 | 1,304,000 | 0,000,000 |
| Scope 2 | 5,530,000 | 0,000,000 |
| Scope 3 | 100,330,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Prestige Consumer Healthcare Inc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
